nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP2C9—Estropipate—osteoporosis	0.0984	0.16	CbGbCtD
Guanfacine—CYP2C19—Cholecalciferol—osteoporosis	0.061	0.099	CbGbCtD
Guanfacine—CYP3A4—Estropipate—osteoporosis	0.0572	0.0929	CbGbCtD
Guanfacine—CYP3A4—Calcitriol—osteoporosis	0.0572	0.0929	CbGbCtD
Guanfacine—CYP2C9—Cholecalciferol—osteoporosis	0.0507	0.0823	CbGbCtD
Guanfacine—CYP2C19—Estradiol—osteoporosis	0.0492	0.0798	CbGbCtD
Guanfacine—CYP3A4—Ergocalciferol—osteoporosis	0.0458	0.0743	CbGbCtD
Guanfacine—CYP2C9—Estradiol—osteoporosis	0.0409	0.0664	CbGbCtD
Guanfacine—CYP3A4—Raloxifene—osteoporosis	0.0382	0.062	CbGbCtD
Guanfacine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0369	0.0599	CbGbCtD
Guanfacine—CYP3A4—Cholecalciferol—osteoporosis	0.0295	0.0479	CbGbCtD
Guanfacine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0271	0.044	CbGbCtD
Guanfacine—CYP3A4—Estradiol—osteoporosis	0.0238	0.0386	CbGbCtD
Guanfacine—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000488	0.00134	CcSEcCtD
Guanfacine—Shock—Risedronate—osteoporosis	0.000487	0.00134	CcSEcCtD
Guanfacine—Discomfort—Pamidronate—osteoporosis	0.000485	0.00134	CcSEcCtD
Guanfacine—Agitation—Zoledronate—osteoporosis	0.000484	0.00133	CcSEcCtD
Guanfacine—Gastrointestinal pain—Calcitriol—osteoporosis	0.000481	0.00133	CcSEcCtD
Guanfacine—Abdominal pain—Raloxifene—osteoporosis	0.00048	0.00132	CcSEcCtD
Guanfacine—Vision blurred—Conjugated Estrogens—osteoporosis	0.000478	0.00132	CcSEcCtD
Guanfacine—Malaise—Zoledronate—osteoporosis	0.000475	0.00131	CcSEcCtD
Guanfacine—Abdominal pain—Ibandronate—osteoporosis	0.000475	0.00131	CcSEcCtD
Guanfacine—Confusional state—Pamidronate—osteoporosis	0.000475	0.00131	CcSEcCtD
Guanfacine—Vertigo—Zoledronate—osteoporosis	0.000474	0.00131	CcSEcCtD
Guanfacine—Syncope—Zoledronate—osteoporosis	0.000473	0.0013	CcSEcCtD
Guanfacine—Oedema—Pamidronate—osteoporosis	0.000471	0.0013	CcSEcCtD
Guanfacine—Rhinitis—Estradiol—osteoporosis	0.000468	0.00129	CcSEcCtD
Guanfacine—Palpitations—Zoledronate—osteoporosis	0.000466	0.00128	CcSEcCtD
Guanfacine—Abdominal pain—Calcitriol—osteoporosis	0.000465	0.00128	CcSEcCtD
Guanfacine—Shock—Pamidronate—osteoporosis	0.000463	0.00128	CcSEcCtD
Guanfacine—Loss of consciousness—Zoledronate—osteoporosis	0.000463	0.00128	CcSEcCtD
Guanfacine—Hypersensitivity—Estropipate—osteoporosis	0.000462	0.00127	CcSEcCtD
Guanfacine—Vomiting—Etidronic acid—osteoporosis	0.000461	0.00127	CcSEcCtD
Guanfacine—Tachycardia—Pamidronate—osteoporosis	0.00046	0.00127	CcSEcCtD
Guanfacine—Rash—Etidronic acid—osteoporosis	0.000457	0.00126	CcSEcCtD
Guanfacine—Convulsion—Zoledronate—osteoporosis	0.000457	0.00126	CcSEcCtD
Guanfacine—Dermatitis—Etidronic acid—osteoporosis	0.000457	0.00126	CcSEcCtD
Guanfacine—Vertigo—Conjugated Estrogens—osteoporosis	0.000456	0.00126	CcSEcCtD
Guanfacine—Hyperhidrosis—Pamidronate—osteoporosis	0.000455	0.00125	CcSEcCtD
Guanfacine—Syncope—Conjugated Estrogens—osteoporosis	0.000455	0.00125	CcSEcCtD
Guanfacine—Hypertension—Zoledronate—osteoporosis	0.000455	0.00125	CcSEcCtD
Guanfacine—Hypersensitivity—Alendronate—osteoporosis	0.000455	0.00125	CcSEcCtD
Guanfacine—Headache—Etidronic acid—osteoporosis	0.000454	0.00125	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000451	0.00124	CcSEcCtD
Guanfacine—Asthenia—Estropipate—osteoporosis	0.00045	0.00124	CcSEcCtD
Guanfacine—Visual impairment—Estradiol—osteoporosis	0.00045	0.00124	CcSEcCtD
Guanfacine—Chest pain—Zoledronate—osteoporosis	0.000449	0.00124	CcSEcCtD
Guanfacine—Arthralgia—Zoledronate—osteoporosis	0.000449	0.00124	CcSEcCtD
Guanfacine—Myalgia—Zoledronate—osteoporosis	0.000449	0.00124	CcSEcCtD
Guanfacine—Palpitations—Conjugated Estrogens—osteoporosis	0.000449	0.00124	CcSEcCtD
Guanfacine—Insomnia—Risedronate—osteoporosis	0.000448	0.00123	CcSEcCtD
Guanfacine—Anxiety—Zoledronate—osteoporosis	0.000447	0.00123	CcSEcCtD
Guanfacine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000446	0.00123	CcSEcCtD
Guanfacine—Paraesthesia—Risedronate—osteoporosis	0.000445	0.00123	CcSEcCtD
Guanfacine—Pruritus—Estropipate—osteoporosis	0.000444	0.00122	CcSEcCtD
Guanfacine—Discomfort—Zoledronate—osteoporosis	0.000443	0.00122	CcSEcCtD
Guanfacine—Asthenia—Alendronate—osteoporosis	0.000443	0.00122	CcSEcCtD
Guanfacine—Hypersensitivity—Ibandronate—osteoporosis	0.000443	0.00122	CcSEcCtD
Guanfacine—Dyspnoea—Risedronate—osteoporosis	0.000442	0.00122	CcSEcCtD
Guanfacine—Hypotension—Pamidronate—osteoporosis	0.00044	0.00121	CcSEcCtD
Guanfacine—Convulsion—Conjugated Estrogens—osteoporosis	0.00044	0.00121	CcSEcCtD
Guanfacine—Dry mouth—Zoledronate—osteoporosis	0.000439	0.00121	CcSEcCtD
Guanfacine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000438	0.00121	CcSEcCtD
Guanfacine—Pruritus—Alendronate—osteoporosis	0.000437	0.0012	CcSEcCtD
Guanfacine—Dyspepsia—Risedronate—osteoporosis	0.000436	0.0012	CcSEcCtD
Guanfacine—Eye disorder—Estradiol—osteoporosis	0.000436	0.0012	CcSEcCtD
Guanfacine—Tinnitus—Estradiol—osteoporosis	0.000435	0.0012	CcSEcCtD
Guanfacine—Constipation—Ethinyl Estradiol—osteoporosis	0.000435	0.0012	CcSEcCtD
Guanfacine—Confusional state—Zoledronate—osteoporosis	0.000434	0.0012	CcSEcCtD
Guanfacine—Hypersensitivity—Calcitriol—osteoporosis	0.000434	0.00119	CcSEcCtD
Guanfacine—Arthralgia—Conjugated Estrogens—osteoporosis	0.000432	0.00119	CcSEcCtD
Guanfacine—Myalgia—Conjugated Estrogens—osteoporosis	0.000432	0.00119	CcSEcCtD
Guanfacine—Chest pain—Conjugated Estrogens—osteoporosis	0.000432	0.00119	CcSEcCtD
Guanfacine—Asthenia—Ibandronate—osteoporosis	0.000431	0.00119	CcSEcCtD
Guanfacine—Anxiety—Conjugated Estrogens—osteoporosis	0.000431	0.00119	CcSEcCtD
Guanfacine—Nausea—Etidronic acid—osteoporosis	0.00043	0.00119	CcSEcCtD
Guanfacine—Oedema—Zoledronate—osteoporosis	0.00043	0.00119	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000429	0.00118	CcSEcCtD
Guanfacine—Diarrhoea—Estropipate—osteoporosis	0.000429	0.00118	CcSEcCtD
Guanfacine—Fatigue—Risedronate—osteoporosis	0.000427	0.00118	CcSEcCtD
Guanfacine—Insomnia—Pamidronate—osteoporosis	0.000426	0.00117	CcSEcCtD
Guanfacine—Pruritus—Ibandronate—osteoporosis	0.000425	0.00117	CcSEcCtD
Guanfacine—Constipation—Risedronate—osteoporosis	0.000424	0.00117	CcSEcCtD
Guanfacine—Shock—Zoledronate—osteoporosis	0.000423	0.00117	CcSEcCtD
Guanfacine—Paraesthesia—Pamidronate—osteoporosis	0.000423	0.00117	CcSEcCtD
Guanfacine—Diarrhoea—Alendronate—osteoporosis	0.000423	0.00116	CcSEcCtD
Guanfacine—Asthenia—Calcitriol—osteoporosis	0.000422	0.00116	CcSEcCtD
Guanfacine—Immune system disorder—Estradiol—osteoporosis	0.000422	0.00116	CcSEcCtD
Guanfacine—Dyspnoea—Pamidronate—osteoporosis	0.00042	0.00116	CcSEcCtD
Guanfacine—Tachycardia—Zoledronate—osteoporosis	0.00042	0.00116	CcSEcCtD
Guanfacine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000419	0.00115	CcSEcCtD
Guanfacine—Somnolence—Pamidronate—osteoporosis	0.000419	0.00115	CcSEcCtD
Guanfacine—Pruritus—Calcitriol—osteoporosis	0.000416	0.00115	CcSEcCtD
Guanfacine—Hyperhidrosis—Zoledronate—osteoporosis	0.000416	0.00115	CcSEcCtD
Guanfacine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000416	0.00115	CcSEcCtD
Guanfacine—Diarrhoea—Raloxifene—osteoporosis	0.000416	0.00115	CcSEcCtD
Guanfacine—Dyspepsia—Pamidronate—osteoporosis	0.000415	0.00114	CcSEcCtD
Guanfacine—Dizziness—Estropipate—osteoporosis	0.000415	0.00114	CcSEcCtD
Guanfacine—Oedema—Conjugated Estrogens—osteoporosis	0.000414	0.00114	CcSEcCtD
Guanfacine—Alopecia—Estradiol—osteoporosis	0.000412	0.00114	CcSEcCtD
Guanfacine—Diarrhoea—Ibandronate—osteoporosis	0.000411	0.00113	CcSEcCtD
Guanfacine—Decreased appetite—Pamidronate—osteoporosis	0.000409	0.00113	CcSEcCtD
Guanfacine—Dizziness—Alendronate—osteoporosis	0.000408	0.00113	CcSEcCtD
Guanfacine—Shock—Conjugated Estrogens—osteoporosis	0.000408	0.00112	CcSEcCtD
Guanfacine—Fatigue—Pamidronate—osteoporosis	0.000406	0.00112	CcSEcCtD
Guanfacine—Gastrointestinal pain—Risedronate—osteoporosis	0.000405	0.00112	CcSEcCtD
Guanfacine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000404	0.00111	CcSEcCtD
Guanfacine—Constipation—Pamidronate—osteoporosis	0.000403	0.00111	CcSEcCtD
Guanfacine—Diarrhoea—Calcitriol—osteoporosis	0.000403	0.00111	CcSEcCtD
Guanfacine—Hypotension—Zoledronate—osteoporosis	0.000402	0.00111	CcSEcCtD
Guanfacine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000402	0.00111	CcSEcCtD
Guanfacine—Dizziness—Raloxifene—osteoporosis	0.000402	0.00111	CcSEcCtD
Guanfacine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.0004	0.0011	CcSEcCtD
Guanfacine—Tension—Estradiol—osteoporosis	0.000399	0.0011	CcSEcCtD
Guanfacine—Vomiting—Estropipate—osteoporosis	0.000399	0.0011	CcSEcCtD
Guanfacine—Dysgeusia—Estradiol—osteoporosis	0.000398	0.0011	CcSEcCtD
Guanfacine—Dizziness—Ibandronate—osteoporosis	0.000398	0.0011	CcSEcCtD
Guanfacine—Rash—Estropipate—osteoporosis	0.000395	0.00109	CcSEcCtD
Guanfacine—Dermatitis—Estropipate—osteoporosis	0.000395	0.00109	CcSEcCtD
Guanfacine—Nervousness—Estradiol—osteoporosis	0.000395	0.00109	CcSEcCtD
Guanfacine—Headache—Estropipate—osteoporosis	0.000393	0.00108	CcSEcCtD
Guanfacine—Vomiting—Alendronate—osteoporosis	0.000393	0.00108	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000392	0.00108	CcSEcCtD
Guanfacine—Abdominal pain—Risedronate—osteoporosis	0.000392	0.00108	CcSEcCtD
Guanfacine—Muscle spasms—Estradiol—osteoporosis	0.000391	0.00108	CcSEcCtD
Guanfacine—Rash—Alendronate—osteoporosis	0.000389	0.00107	CcSEcCtD
Guanfacine—Insomnia—Zoledronate—osteoporosis	0.000389	0.00107	CcSEcCtD
Guanfacine—Dermatitis—Alendronate—osteoporosis	0.000389	0.00107	CcSEcCtD
Guanfacine—Feeling abnormal—Pamidronate—osteoporosis	0.000388	0.00107	CcSEcCtD
Guanfacine—Hypotension—Conjugated Estrogens—osteoporosis	0.000387	0.00107	CcSEcCtD
Guanfacine—Headache—Alendronate—osteoporosis	0.000387	0.00107	CcSEcCtD
Guanfacine—Paraesthesia—Zoledronate—osteoporosis	0.000386	0.00106	CcSEcCtD
Guanfacine—Vomiting—Raloxifene—osteoporosis	0.000386	0.00106	CcSEcCtD
Guanfacine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000385	0.00106	CcSEcCtD
Guanfacine—Dyspnoea—Zoledronate—osteoporosis	0.000384	0.00106	CcSEcCtD
Guanfacine—Rash—Raloxifene—osteoporosis	0.000383	0.00106	CcSEcCtD
Guanfacine—Dermatitis—Raloxifene—osteoporosis	0.000383	0.00105	CcSEcCtD
Guanfacine—Somnolence—Zoledronate—osteoporosis	0.000382	0.00105	CcSEcCtD
Guanfacine—Vomiting—Ibandronate—osteoporosis	0.000382	0.00105	CcSEcCtD
Guanfacine—Tremor—Estradiol—osteoporosis	0.000381	0.00105	CcSEcCtD
Guanfacine—Headache—Raloxifene—osteoporosis	0.00038	0.00105	CcSEcCtD
Guanfacine—Rash—Ibandronate—osteoporosis	0.000379	0.00104	CcSEcCtD
Guanfacine—Dermatitis—Ibandronate—osteoporosis	0.000379	0.00104	CcSEcCtD
Guanfacine—Dyspepsia—Zoledronate—osteoporosis	0.000379	0.00104	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000377	0.00104	CcSEcCtD
Guanfacine—Ill-defined disorder—Estradiol—osteoporosis	0.000377	0.00104	CcSEcCtD
Guanfacine—Headache—Ibandronate—osteoporosis	0.000377	0.00104	CcSEcCtD
Guanfacine—Insomnia—Conjugated Estrogens—osteoporosis	0.000375	0.00103	CcSEcCtD
Guanfacine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000374	0.00103	CcSEcCtD
Guanfacine—Vomiting—Calcitriol—osteoporosis	0.000374	0.00103	CcSEcCtD
Guanfacine—Decreased appetite—Zoledronate—osteoporosis	0.000374	0.00103	CcSEcCtD
Guanfacine—Agitation—Estradiol—osteoporosis	0.000373	0.00103	CcSEcCtD
Guanfacine—Nausea—Estropipate—osteoporosis	0.000372	0.00103	CcSEcCtD
Guanfacine—Abdominal pain—Pamidronate—osteoporosis	0.000372	0.00103	CcSEcCtD
Guanfacine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000372	0.00103	CcSEcCtD
Guanfacine—Rash—Calcitriol—osteoporosis	0.000371	0.00102	CcSEcCtD
Guanfacine—Fatigue—Zoledronate—osteoporosis	0.000371	0.00102	CcSEcCtD
Guanfacine—Dermatitis—Calcitriol—osteoporosis	0.000371	0.00102	CcSEcCtD
Guanfacine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000369	0.00102	CcSEcCtD
Guanfacine—Headache—Calcitriol—osteoporosis	0.000369	0.00102	CcSEcCtD
Guanfacine—Somnolence—Conjugated Estrogens—osteoporosis	0.000368	0.00101	CcSEcCtD
Guanfacine—Constipation—Zoledronate—osteoporosis	0.000368	0.00101	CcSEcCtD
Guanfacine—Nausea—Alendronate—osteoporosis	0.000367	0.00101	CcSEcCtD
Guanfacine—Malaise—Estradiol—osteoporosis	0.000366	0.00101	CcSEcCtD
Guanfacine—Hypersensitivity—Risedronate—osteoporosis	0.000365	0.00101	CcSEcCtD
Guanfacine—Vertigo—Estradiol—osteoporosis	0.000365	0.00101	CcSEcCtD
Guanfacine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000365	0.001	CcSEcCtD
Guanfacine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000365	0.001	CcSEcCtD
Guanfacine—Syncope—Estradiol—osteoporosis	0.000364	0.001	CcSEcCtD
Guanfacine—Nausea—Raloxifene—osteoporosis	0.000361	0.000994	CcSEcCtD
Guanfacine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00036	0.000992	CcSEcCtD
Guanfacine—Pruritus—Ethinyl Estradiol—osteoporosis	0.00036	0.000991	CcSEcCtD
Guanfacine—Palpitations—Estradiol—osteoporosis	0.000359	0.000989	CcSEcCtD
Guanfacine—Fatigue—Conjugated Estrogens—osteoporosis	0.000357	0.000984	CcSEcCtD
Guanfacine—Nausea—Ibandronate—osteoporosis	0.000357	0.000984	CcSEcCtD
Guanfacine—Loss of consciousness—Estradiol—osteoporosis	0.000357	0.000984	CcSEcCtD
Guanfacine—Asthenia—Risedronate—osteoporosis	0.000355	0.00098	CcSEcCtD
Guanfacine—Feeling abnormal—Zoledronate—osteoporosis	0.000355	0.000977	CcSEcCtD
Guanfacine—Constipation—Conjugated Estrogens—osteoporosis	0.000354	0.000976	CcSEcCtD
Guanfacine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000352	0.000969	CcSEcCtD
Guanfacine—Hypertension—Estradiol—osteoporosis	0.000351	0.000967	CcSEcCtD
Guanfacine—Pruritus—Risedronate—osteoporosis	0.000351	0.000966	CcSEcCtD
Guanfacine—Nausea—Calcitriol—osteoporosis	0.00035	0.000963	CcSEcCtD
Guanfacine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000348	0.000958	CcSEcCtD
Guanfacine—Hypersensitivity—Pamidronate—osteoporosis	0.000347	0.000956	CcSEcCtD
Guanfacine—Myalgia—Estradiol—osteoporosis	0.000346	0.000953	CcSEcCtD
Guanfacine—Arthralgia—Estradiol—osteoporosis	0.000346	0.000953	CcSEcCtD
Guanfacine—Chest pain—Estradiol—osteoporosis	0.000346	0.000953	CcSEcCtD
Guanfacine—Anxiety—Estradiol—osteoporosis	0.000345	0.00095	CcSEcCtD
Guanfacine—Discomfort—Estradiol—osteoporosis	0.000342	0.000942	CcSEcCtD
Guanfacine—Abdominal pain—Zoledronate—osteoporosis	0.00034	0.000937	CcSEcCtD
Guanfacine—Diarrhoea—Risedronate—osteoporosis	0.000339	0.000934	CcSEcCtD
Guanfacine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000339	0.000933	CcSEcCtD
Guanfacine—Dry mouth—Estradiol—osteoporosis	0.000338	0.000932	CcSEcCtD
Guanfacine—Asthenia—Pamidronate—osteoporosis	0.000338	0.000931	CcSEcCtD
Guanfacine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000336	0.000926	CcSEcCtD
Guanfacine—Confusional state—Estradiol—osteoporosis	0.000334	0.000921	CcSEcCtD
Guanfacine—Pruritus—Pamidronate—osteoporosis	0.000333	0.000918	CcSEcCtD
Guanfacine—Oedema—Estradiol—osteoporosis	0.000332	0.000914	CcSEcCtD
Guanfacine—Dizziness—Risedronate—osteoporosis	0.000328	0.000903	CcSEcCtD
Guanfacine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000327	0.000902	CcSEcCtD
Guanfacine—Shock—Estradiol—osteoporosis	0.000326	0.000899	CcSEcCtD
Guanfacine—Tachycardia—Estradiol—osteoporosis	0.000324	0.000892	CcSEcCtD
Guanfacine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000323	0.00089	CcSEcCtD
Guanfacine—Diarrhoea—Pamidronate—osteoporosis	0.000322	0.000888	CcSEcCtD
Guanfacine—Hyperhidrosis—Estradiol—osteoporosis	0.000321	0.000883	CcSEcCtD
Guanfacine—Rash—Ethinyl Estradiol—osteoporosis	0.00032	0.000883	CcSEcCtD
Guanfacine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00032	0.000882	CcSEcCtD
Guanfacine—Headache—Ethinyl Estradiol—osteoporosis	0.000318	0.000877	CcSEcCtD
Guanfacine—Hypersensitivity—Zoledronate—osteoporosis	0.000317	0.000873	CcSEcCtD
Guanfacine—Vomiting—Risedronate—osteoporosis	0.000315	0.000868	CcSEcCtD
Guanfacine—Rash—Risedronate—osteoporosis	0.000312	0.000861	CcSEcCtD
Guanfacine—Dermatitis—Risedronate—osteoporosis	0.000312	0.00086	CcSEcCtD
Guanfacine—Dizziness—Pamidronate—osteoporosis	0.000311	0.000858	CcSEcCtD
Guanfacine—Headache—Risedronate—osteoporosis	0.00031	0.000855	CcSEcCtD
Guanfacine—Asthenia—Zoledronate—osteoporosis	0.000309	0.000851	CcSEcCtD
Guanfacine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000305	0.000841	CcSEcCtD
Guanfacine—Pruritus—Zoledronate—osteoporosis	0.000304	0.000839	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000302	0.000832	CcSEcCtD
Guanfacine—Nausea—Ethinyl Estradiol—osteoporosis	0.000302	0.000832	CcSEcCtD
Guanfacine—Insomnia—Estradiol—osteoporosis	0.0003	0.000826	CcSEcCtD
Guanfacine—Vomiting—Pamidronate—osteoporosis	0.000299	0.000825	CcSEcCtD
Guanfacine—Paraesthesia—Estradiol—osteoporosis	0.000298	0.00082	CcSEcCtD
Guanfacine—Asthenia—Conjugated Estrogens—osteoporosis	0.000297	0.000819	CcSEcCtD
Guanfacine—Rash—Pamidronate—osteoporosis	0.000297	0.000818	CcSEcCtD
Guanfacine—Dermatitis—Pamidronate—osteoporosis	0.000297	0.000818	CcSEcCtD
Guanfacine—Dyspnoea—Estradiol—osteoporosis	0.000296	0.000815	CcSEcCtD
Guanfacine—Headache—Pamidronate—osteoporosis	0.000295	0.000813	CcSEcCtD
Guanfacine—Somnolence—Estradiol—osteoporosis	0.000295	0.000812	CcSEcCtD
Guanfacine—Diarrhoea—Zoledronate—osteoporosis	0.000294	0.000811	CcSEcCtD
Guanfacine—Nausea—Risedronate—osteoporosis	0.000294	0.000811	CcSEcCtD
Guanfacine—Pruritus—Conjugated Estrogens—osteoporosis	0.000293	0.000808	CcSEcCtD
Guanfacine—Dyspepsia—Estradiol—osteoporosis	0.000292	0.000804	CcSEcCtD
Guanfacine—Decreased appetite—Estradiol—osteoporosis	0.000288	0.000794	CcSEcCtD
Guanfacine—Fatigue—Estradiol—osteoporosis	0.000286	0.000788	CcSEcCtD
Guanfacine—Dizziness—Zoledronate—osteoporosis	0.000284	0.000784	CcSEcCtD
Guanfacine—Constipation—Estradiol—osteoporosis	0.000284	0.000781	CcSEcCtD
Guanfacine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000283	0.000781	CcSEcCtD
Guanfacine—Nausea—Pamidronate—osteoporosis	0.00028	0.000771	CcSEcCtD
Guanfacine—Dizziness—Conjugated Estrogens—osteoporosis	0.000274	0.000755	CcSEcCtD
Guanfacine—Vomiting—Zoledronate—osteoporosis	0.000274	0.000754	CcSEcCtD
Guanfacine—Feeling abnormal—Estradiol—osteoporosis	0.000273	0.000753	CcSEcCtD
Guanfacine—Rash—Zoledronate—osteoporosis	0.000271	0.000748	CcSEcCtD
Guanfacine—Gastrointestinal pain—Estradiol—osteoporosis	0.000271	0.000747	CcSEcCtD
Guanfacine—Dermatitis—Zoledronate—osteoporosis	0.000271	0.000747	CcSEcCtD
Guanfacine—Headache—Zoledronate—osteoporosis	0.00027	0.000743	CcSEcCtD
Guanfacine—Vomiting—Conjugated Estrogens—osteoporosis	0.000263	0.000726	CcSEcCtD
Guanfacine—Abdominal pain—Estradiol—osteoporosis	0.000262	0.000722	CcSEcCtD
Guanfacine—Rash—Conjugated Estrogens—osteoporosis	0.000261	0.00072	CcSEcCtD
Guanfacine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000261	0.000719	CcSEcCtD
Guanfacine—Headache—Conjugated Estrogens—osteoporosis	0.00026	0.000715	CcSEcCtD
Guanfacine—Nausea—Zoledronate—osteoporosis	0.000256	0.000704	CcSEcCtD
Guanfacine—Nausea—Conjugated Estrogens—osteoporosis	0.000246	0.000678	CcSEcCtD
Guanfacine—Hypersensitivity—Estradiol—osteoporosis	0.000244	0.000673	CcSEcCtD
Guanfacine—Asthenia—Estradiol—osteoporosis	0.000238	0.000656	CcSEcCtD
Guanfacine—Pruritus—Estradiol—osteoporosis	0.000235	0.000646	CcSEcCtD
Guanfacine—Diarrhoea—Estradiol—osteoporosis	0.000227	0.000625	CcSEcCtD
Guanfacine—Dizziness—Estradiol—osteoporosis	0.000219	0.000604	CcSEcCtD
Guanfacine—Vomiting—Estradiol—osteoporosis	0.000211	0.000581	CcSEcCtD
Guanfacine—Rash—Estradiol—osteoporosis	0.000209	0.000576	CcSEcCtD
Guanfacine—Dermatitis—Estradiol—osteoporosis	0.000209	0.000576	CcSEcCtD
Guanfacine—Headache—Estradiol—osteoporosis	0.000208	0.000572	CcSEcCtD
Guanfacine—Nausea—Estradiol—osteoporosis	0.000197	0.000543	CcSEcCtD
Guanfacine—ADRA2B—Signaling by GPCR—MGLL—osteoporosis	5.5e-05	0.00259	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR ligand binding—PTH—osteoporosis	5.38e-05	0.00254	CbGpPWpGaD
Guanfacine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.29e-05	0.00249	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PTH1R—osteoporosis	5.25e-05	0.00248	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CALCR—osteoporosis	5.25e-05	0.00248	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR ligand binding—CNR2—osteoporosis	5.24e-05	0.00247	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR ligand binding—CALCA—osteoporosis	5.17e-05	0.00244	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—FGB—osteoporosis	5.14e-05	0.00242	CbGpPWpGaD
Guanfacine—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	5.13e-05	0.00242	CbGpPWpGaD
Guanfacine—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	5.06e-05	0.00238	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR ligand binding—WNT1—osteoporosis	4.93e-05	0.00232	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	4.81e-05	0.00227	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—RAP1A—osteoporosis	4.73e-05	0.00223	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	4.69e-05	0.00221	CbGpPWpGaD
Guanfacine—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	4.68e-05	0.0022	CbGpPWpGaD
Guanfacine—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	4.61e-05	0.00217	CbGpPWpGaD
Guanfacine—ADRA2A—G alpha (i) signalling events—ADCY5—osteoporosis	4.61e-05	0.00217	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—MGLL—osteoporosis	4.6e-05	0.00217	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SOST—osteoporosis	4.52e-05	0.00213	CbGpPWpGaD
Guanfacine—ADRA2B—Platelet activation, signaling and aggregation—IGF1—osteoporosis	4.51e-05	0.00213	CbGpPWpGaD
Guanfacine—ADRA2B—G alpha (i) signalling events—POMC—osteoporosis	4.47e-05	0.00211	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR ligand binding—PTHLH—osteoporosis	4.46e-05	0.0021	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	4.39e-05	0.00207	CbGpPWpGaD
Guanfacine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	4.3e-05	0.00203	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—FGA—osteoporosis	4.29e-05	0.00202	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	4.28e-05	0.00202	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—MGLL—osteoporosis	4.17e-05	0.00197	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PKM—osteoporosis	4.1e-05	0.00193	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—FDPS—osteoporosis	4.1e-05	0.00193	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CALCR—osteoporosis	4.09e-05	0.00193	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PTH1R—osteoporosis	4.09e-05	0.00193	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—PTH—osteoporosis	4.01e-05	0.00189	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR ligand binding—CALCA—osteoporosis	3.92e-05	0.00185	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—CNR2—osteoporosis	3.9e-05	0.00184	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—FGB—osteoporosis	3.9e-05	0.00184	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PGLS—osteoporosis	3.89e-05	0.00183	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—GPD2—osteoporosis	3.89e-05	0.00183	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.75e-05	0.00177	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—PTH—osteoporosis	3.64e-05	0.00171	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ATIC—osteoporosis	3.56e-05	0.00168	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PNP—osteoporosis	3.56e-05	0.00168	CbGpPWpGaD
Guanfacine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	3.55e-05	0.00167	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—CNR2—osteoporosis	3.54e-05	0.00167	CbGpPWpGaD
Guanfacine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.49e-05	0.00165	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SOST—osteoporosis	3.43e-05	0.00162	CbGpPWpGaD
Guanfacine—ADRA2A—Platelet activation, signaling and aggregation—IGF1—osteoporosis	3.43e-05	0.00161	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.42e-05	0.00161	CbGpPWpGaD
Guanfacine—ADRA2A—G alpha (i) signalling events—POMC—osteoporosis	3.39e-05	0.0016	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—WNT1—osteoporosis	3.33e-05	0.00157	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—PTHLH—osteoporosis	3.32e-05	0.00156	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MGLL—osteoporosis	3.25e-05	0.00153	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.19e-05	0.0015	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—LRP5—osteoporosis	3.17e-05	0.0015	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CALCR—osteoporosis	3.1e-05	0.00146	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PTH1R—osteoporosis	3.1e-05	0.00146	CbGpPWpGaD
Guanfacine—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	3.08e-05	0.00145	CbGpPWpGaD
Guanfacine—CYP2C19—Biological oxidations—POMC—osteoporosis	3.08e-05	0.00145	CbGpPWpGaD
Guanfacine—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	3.04e-05	0.00143	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—PTH—osteoporosis	3.04e-05	0.00143	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—LRP6—osteoporosis	3.03e-05	0.00143	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CA2—osteoporosis	3.03e-05	0.00143	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—OXCT1—osteoporosis	3.03e-05	0.00143	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—PTHLH—osteoporosis	3.01e-05	0.00142	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—CNR2—osteoporosis	2.96e-05	0.0014	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—MGLL—osteoporosis	2.95e-05	0.00139	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—CALCA—osteoporosis	2.92e-05	0.00138	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PKM—osteoporosis	2.91e-05	0.00137	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—FDPS—osteoporosis	2.91e-05	0.00137	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.91e-05	0.00137	CbGpPWpGaD
Guanfacine—CYP2C9—Biological oxidations—POMC—osteoporosis	2.81e-05	0.00133	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PTH—osteoporosis	2.76e-05	0.0013	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GPD2—osteoporosis	2.76e-05	0.0013	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PGLS—osteoporosis	2.76e-05	0.0013	CbGpPWpGaD
Guanfacine—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	2.71e-05	0.00128	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR ligand binding—POMC—osteoporosis	2.71e-05	0.00128	CbGpPWpGaD
Guanfacine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	2.7e-05	0.00127	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CNR2—osteoporosis	2.69e-05	0.00127	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—CALCA—osteoporosis	2.65e-05	0.00125	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PKM—osteoporosis	2.65e-05	0.00125	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—FDPS—osteoporosis	2.65e-05	0.00125	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TLN1—osteoporosis	2.56e-05	0.00121	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—WNT1—osteoporosis	2.53e-05	0.00119	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ATIC—osteoporosis	2.52e-05	0.00119	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PNP—osteoporosis	2.52e-05	0.00119	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—PTHLH—osteoporosis	2.52e-05	0.00119	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PGLS—osteoporosis	2.51e-05	0.00118	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GPD2—osteoporosis	2.51e-05	0.00118	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—IDH2—osteoporosis	2.51e-05	0.00118	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MGLL—osteoporosis	2.47e-05	0.00116	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—LRP5—osteoporosis	2.41e-05	0.00113	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CYP27A1—osteoporosis	2.36e-05	0.00111	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—IGF1—osteoporosis	2.33e-05	0.0011	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—LRP6—osteoporosis	2.3e-05	0.00109	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ATIC—osteoporosis	2.3e-05	0.00108	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PNP—osteoporosis	2.3e-05	0.00108	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ACP5—osteoporosis	2.29e-05	0.00108	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PTHLH—osteoporosis	2.29e-05	0.00108	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—CALCA—osteoporosis	2.22e-05	0.00105	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—P4HB—osteoporosis	2.21e-05	0.00104	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PTH—osteoporosis	2.15e-05	0.00101	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CA2—osteoporosis	2.14e-05	0.00101	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—OXCT1—osteoporosis	2.14e-05	0.00101	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—TPI1—osteoporosis	2.13e-05	0.001	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—RAP1A—osteoporosis	2.11e-05	0.000995	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CNR2—osteoporosis	2.09e-05	0.000987	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—MGLL—osteoporosis	2.09e-05	0.000985	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—ADCY5—osteoporosis	2.08e-05	0.00098	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NFATC1—osteoporosis	2.06e-05	0.000971	CbGpPWpGaD
Guanfacine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	2.05e-05	0.000968	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR ligand binding—POMC—osteoporosis	2.05e-05	0.000968	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—DKK1—osteoporosis	2.04e-05	0.000963	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CALCA—osteoporosis	2.01e-05	0.000949	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—P4HB—osteoporosis	2e-05	0.000945	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.97e-05	0.000929	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—WNT1—osteoporosis	1.97e-05	0.000928	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—GAPDH—osteoporosis	1.97e-05	0.000927	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—OXCT1—osteoporosis	1.95e-05	0.000921	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CA2—osteoporosis	1.95e-05	0.000921	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TLN1—osteoporosis	1.94e-05	0.000916	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—RAP1A—osteoporosis	1.92e-05	0.000903	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—FGA—osteoporosis	1.92e-05	0.000903	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—MGLL—osteoporosis	1.9e-05	0.000898	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—ADCY5—osteoporosis	1.89e-05	0.00089	CbGpPWpGaD
Guanfacine—CYP3A4—Biological oxidations—POMC—osteoporosis	1.85e-05	0.000874	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.8e-05	0.000847	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PTHLH—osteoporosis	1.78e-05	0.000839	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—BMP2—osteoporosis	1.78e-05	0.000839	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—IDH2—osteoporosis	1.78e-05	0.000837	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—IGF1—osteoporosis	1.77e-05	0.000832	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—FDPS—osteoporosis	1.75e-05	0.000824	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PKM—osteoporosis	1.75e-05	0.000824	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—FGB—osteoporosis	1.74e-05	0.000821	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PSMA2—osteoporosis	1.68e-05	0.000793	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PSMA5—osteoporosis	1.68e-05	0.000793	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—P4HB—osteoporosis	1.68e-05	0.00079	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP27A1—osteoporosis	1.67e-05	0.000787	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GPD2—osteoporosis	1.66e-05	0.000781	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PGLS—osteoporosis	1.66e-05	0.000781	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PTH—osteoporosis	1.63e-05	0.000769	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ACP5—osteoporosis	1.62e-05	0.000766	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—IDH2—osteoporosis	1.62e-05	0.000763	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.6e-05	0.000756	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—RAP1A—osteoporosis	1.6e-05	0.000755	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CNR2—osteoporosis	1.59e-05	0.000749	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—ADCY5—osteoporosis	1.58e-05	0.000743	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CALCA—osteoporosis	1.57e-05	0.000739	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NFATC1—osteoporosis	1.56e-05	0.000737	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—DKK1—osteoporosis	1.55e-05	0.000731	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ENO1—osteoporosis	1.55e-05	0.00073	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—POMC—osteoporosis	1.53e-05	0.000721	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PSMA5—osteoporosis	1.53e-05	0.000719	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PSMA2—osteoporosis	1.53e-05	0.000719	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.52e-05	0.000718	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PNP—osteoporosis	1.52e-05	0.000715	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ATIC—osteoporosis	1.52e-05	0.000715	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—TPI1—osteoporosis	1.51e-05	0.000712	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—WNT1—osteoporosis	1.49e-05	0.000704	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ACP5—osteoporosis	1.48e-05	0.000698	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.46e-05	0.000689	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FGA—osteoporosis	1.45e-05	0.000685	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—ADCY5—osteoporosis	1.43e-05	0.000675	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—KL—osteoporosis	1.42e-05	0.000671	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—P4HB—osteoporosis	1.42e-05	0.000669	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—TGFB1—osteoporosis	1.39e-05	0.000658	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GAPDH—osteoporosis	1.39e-05	0.000657	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—POMC—osteoporosis	1.39e-05	0.000654	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—TPI1—osteoporosis	1.38e-05	0.000649	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—RAP1A—osteoporosis	1.36e-05	0.00064	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—IL6R—osteoporosis	1.35e-05	0.000638	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PTHLH—osteoporosis	1.35e-05	0.000637	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—BMP2—osteoporosis	1.35e-05	0.000637	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FGB—osteoporosis	1.32e-05	0.000623	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—P4HB—osteoporosis	1.29e-05	0.00061	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CA2—osteoporosis	1.29e-05	0.000608	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—OXCT1—osteoporosis	1.29e-05	0.000608	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PSMA2—osteoporosis	1.28e-05	0.000602	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PSMA5—osteoporosis	1.28e-05	0.000602	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GAPDH—osteoporosis	1.27e-05	0.000599	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—MGLL—osteoporosis	1.26e-05	0.000592	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CYP19A1—osteoporosis	1.24e-05	0.000584	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—RAP1A—osteoporosis	1.24e-05	0.000583	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CALCA—osteoporosis	1.19e-05	0.000561	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.18e-05	0.000558	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	1.16e-05	0.000547	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—ADCY5—osteoporosis	1.11e-05	0.000526	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ENO1—osteoporosis	1.1e-05	0.000517	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PSMA2—osteoporosis	1.08e-05	0.00051	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PSMA5—osteoporosis	1.08e-05	0.00051	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—KL—osteoporosis	1.08e-05	0.000509	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.08e-05	0.000509	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SPP1—osteoporosis	1.08e-05	0.000509	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—IDH2—osteoporosis	1.07e-05	0.000504	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—TGFB1—osteoporosis	1.06e-05	0.000499	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—POMC—osteoporosis	1.05e-05	0.000497	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	1.03e-05	0.000484	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ADCY5—osteoporosis	1.01e-05	0.000477	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—GPX1—osteoporosis	1.01e-05	0.000475	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP27A1—osteoporosis	1e-05	0.000473	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ENO1—osteoporosis	1e-05	0.000472	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PSMA2—osteoporosis	9.86e-06	0.000465	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PSMA5—osteoporosis	9.86e-06	0.000465	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ACP5—osteoporosis	9.77e-06	0.000461	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IRS2—osteoporosis	9.76e-06	0.00046	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—LEP—osteoporosis	9.55e-06	0.00045	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—MTHFR—osteoporosis	9.3e-06	0.000439	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—ESR1—osteoporosis	9.11e-06	0.00043	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—TPI1—osteoporosis	9.08e-06	0.000428	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP19A1—osteoporosis	8.77e-06	0.000414	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—P4HB—osteoporosis	8.54e-06	0.000403	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IRS1—osteoporosis	8.52e-06	0.000401	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	8.46e-06	0.000399	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GAPDH—osteoporosis	8.38e-06	0.000395	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—POMC—osteoporosis	8.2e-06	0.000387	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SPP1—osteoporosis	8.18e-06	0.000386	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—RAP1A—osteoporosis	8.16e-06	0.000385	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL6R—osteoporosis	8e-06	0.000377	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP19A1—osteoporosis	8e-06	0.000377	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IGF1—osteoporosis	7.89e-06	0.000372	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—POMC—osteoporosis	7.44e-06	0.000351	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IRS2—osteoporosis	7.4e-06	0.000349	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—LEP—osteoporosis	7.24e-06	0.000341	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ADCY5—osteoporosis	7.17e-06	0.000338	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GPX1—osteoporosis	7.14e-06	0.000337	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ESR1—osteoporosis	6.92e-06	0.000326	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ENO1—osteoporosis	6.6e-06	0.000311	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—MTHFR—osteoporosis	6.59e-06	0.000311	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ADCY5—osteoporosis	6.54e-06	0.000308	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GPX1—osteoporosis	6.51e-06	0.000307	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PSMA5—osteoporosis	6.5e-06	0.000307	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PSMA2—osteoporosis	6.5e-06	0.000307	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IRS1—osteoporosis	6.46e-06	0.000305	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—POMC—osteoporosis	6.22e-06	0.000293	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL6R—osteoporosis	6.07e-06	0.000286	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—IL6—osteoporosis	6.03e-06	0.000284	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—MTHFR—osteoporosis	6.01e-06	0.000283	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IGF1—osteoporosis	5.99e-06	0.000282	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP19A1—osteoporosis	5.28e-06	0.000249	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—POMC—osteoporosis	5.27e-06	0.000249	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—POMC—osteoporosis	4.81e-06	0.000227	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MYC—osteoporosis	4.74e-06	0.000223	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	4.73e-06	0.000223	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—IL6—osteoporosis	4.58e-06	0.000216	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ADCY5—osteoporosis	4.31e-06	0.000203	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GPX1—osteoporosis	4.3e-06	0.000202	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—MTHFR—osteoporosis	3.96e-06	0.000187	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MYC—osteoporosis	3.6e-06	0.00017	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	3.59e-06	0.000169	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL6—osteoporosis	3.56e-06	0.000168	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—POMC—osteoporosis	3.17e-06	0.000149	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL6—osteoporosis	2.7e-06	0.000127	CbGpPWpGaD
